Decoy20

NSCLC Non-small Cell Lung Cancer

Indaptus Therapeutics, IncPhase 1/2

—

Rating in progress

Decoy20 in NSCLC Non-small Cell Lung Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active